ID: ALA4217072

Max Phase: Preclinical

Molecular Formula: C34H34N4O5

Molecular Weight: 578.67

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  Cc1cc(C)cc(C(=O)N[C@H](Cc2ccc(-c3c(C)noc3C)cc2)C(=O)N[C@@H](Cc2c[nH]c3ccccc23)C(=O)O)c1

Standard InChI:  InChI=1S/C34H34N4O5/c1-19-13-20(2)15-25(14-19)32(39)36-29(16-23-9-11-24(12-10-23)31-21(3)38-43-22(31)4)33(40)37-30(34(41)42)17-26-18-35-28-8-6-5-7-27(26)28/h5-15,18,29-30,35H,16-17H2,1-4H3,(H,36,39)(H,37,40)(H,41,42)/t29-,30+/m1/s1

Standard InChI Key:  WKCRIQVZKIPGCP-IHLOFXLRSA-N

Associated Targets(Human)

Hemoglobin HbA 880 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 578.67Molecular Weight (Monoisotopic): 578.2529AlogP: 5.21#Rotatable Bonds: 10
Polar Surface Area: 137.32Molecular Species: ACIDHBA: 5HBD: 4
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 3.88CX Basic pKa: 1.42CX LogP: 5.34CX LogD: 2.12
Aromatic Rings: 5Heavy Atoms: 43QED Weighted: 0.18Np Likeness Score: -0.56

References

1. Goldstein SR, Liu C, Safo MK, Nakagawa A, Zapol WM, Winkler JD..  (2018)  Design, Synthesis, and Biological Evaluation of Allosteric Effectors That Enhance CO Release from Carboxyhemoglobin.,  (7): [PMID:30034606] [10.1021/acsmedchemlett.8b00166]

Source